Today’s Stock Alert: Medizone International Inc (MZEI) Institutional Investor Sentiment Is 0.5

November 22, 2016 - By Dolores Ford   ·   0 Comments

Today's Stock Alert: Medizone International Inc (MZEI) Institutional Investor Sentiment Is 0.5

Sentiment for Medizone International Inc (MZEI)

Medizone International Inc (MZEI) institutional sentiment 0.5 in 2016 Q2. Its in 2016Q1. The ratio [12345], as 1 active investment managers increased or opened new positions, while 0 reduced and sold equity positions in Medizone International Inc. The active investment managers in our partner’s database now hold: 1.01 million shares, up from 165,287 shares in 2016Q1. Also, the number of active investment managers holding Medizone International Inc in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 0 Reduced: 0 Increased: 0 New Position: 1.

Medizone International, Inc. is engaged in designing, manufacturing and selling a system using ozone in the disinfection of surgical and other medical treatment facilities and in other applications. The company has a market cap of $24.92 million. The Company’s AsepticSure is an ozone technology, which is used for the purpose of decontaminating and disinfecting hospital surgical suites, emergency rooms, intensive care units and other enclosed spaces, such as gym locker rooms, laboratories and veterinary clinics. It currently has negative earnings. In the AsepticSure system, oxygen atoms are misted into the environment with a hydrogen peroxide vapor and the system’s formula creates Trioxidane.

About 1.55M shares traded hands or 707.98% up from the average. Medizone International Inc (MZEI) has risen 200.00% since April 20, 2016 and is uptrending. It has outperformed by 195.44% the S&P500.

According to Zacks Investment Research, “Medizone International, Inc. designs, manufactures and sells AsepticSure(R) hospital disinfection system primarily in the United States. Medizone International, Inc. is based in Sausalito, California.”

First Western Capital Management Co holds 0.01% of its portfolio in Medizone International Inc for 340,000 shares. Busey Trust Co owns 94,787 shares or 0% of their US portfolio. Moreover, First National Trust Co has 0% invested in the company for 13,500 shares. The Pennsylvania-based Pnc Financial Services Group Inc. has invested 0% in the stock. Vantage Investment Advisors Llc, a Pennsylvania-based fund reported 40,000 shares.#img1#

MZEI Company Profile

Medizone International, Inc., incorporated on August 27, 1984, is engaged in designing, manufacturing and selling a system using ozone in the disinfection of surgical and other medical treatment facilities and in other applications. The Company’s AsepticSure is an ozone technology, which is used for the purpose of decontaminating and disinfecting hospital surgical suites, emergency rooms, intensive care units and other enclosed spaces, such as gym locker rooms, laboratories and veterinary clinics. In the AsepticSure system, oxygen atoms are misted into the environment with a hydrogen peroxide vapor and the system’s formula creates Trioxidane. The Firm is developing a variant of AsepticSure for governmental use with bio-terrorism countermeasures.

More recent Medizone International Inc (OTCMKTS:MZEI) news were published by: Prnewswire.com which released: “Medizone International, Manufacturer of AsepticSure, Closes Additional Investment” on October 27, 2016. Also Bna.com published the news titled: “Medizone Can’t Omit Resolution Over Board Age Limit” on August 26, 2016. Prnewswire.com‘s news article titled: “Medizone International Selects Cogmedix as Medical Device Manufacturing …” with publication date: July 19, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Dolores Ford


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>